Why Are We Vaccinating People Who Have Recovered from COVID-19?

The most effective use of limited supplies would be restricted to those who have never been infected.

Share this story

A worker of the New York City Fire Department Bureau of Emergency Medical Services receives a COVID-19 Moderna vaccine in New York City, December 23, 2020.

Carlo Allegri/Reuters

Now that Pfizer and Moderna have received emergency-use authorizations for their COVID-19 vaccines, the tough work of deciding how to allocate the limited supply of doses begins. Both vaccines, which require two doses per person, will be in short supply for months, and the shortage will be exacerbated by the CDC’s counterintuitive and counterproductive recommendation that people who have already had COVID-19 be offered the new vaccines along with people who have never been infected with the SARS-CoV-2 virus, which causes the disease.

Why, in the middle of a pandemic, when limited supplies necessitate vaccine rationing, does the CDC recommend vaccinating people who are likely already immune? The experts claim that the nature and duration of protective immunity generated by exposure to SARS-CoV-2 is unknown, so even recovered patients should be vaccinated. This rationale runs counter to what we know about viruses in general and about SARS-CoV-2 in particular.

Joel Zinberg

About the Author

Joel Zinberg

Joel Zinberg is a director of the Paragon Health Institute’s Public Health and American Well-Being Initiative. He served as senior economist and general counsel at the White House Council of Economic Advisers, 2017–19.

Comments

Advertisement

Advertisement